Pacific Biomarkers Inc. Awarded Nine Contracts in Early 2011 for Studies in Immunogenicity, Diabetes and Other Areas

Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, has been awarded by one sponsor, nine contracts in early 2011 with a total value of approximately $920,000. The nine contracts are in the areas... - April 29, 2011 - Pacific Biomarkers Inc

Novus Biologicals Announces New USP22 Antibody Made Using SDIX's Genomic Antibody Technology™

Novus Biologicals announced today a new USP22 antibody (catalog number NBP1-49644) for the study of ubiquitin-dependent metabolic pathways. This USP 22 antibody was made using SDIX's Genomic Antibody TechnologyTM (GATTM). Deubiquitinating enzymes (DUBs) comprise a large group of proteases that... - April 28, 2011 - Novus Biologicals

Novus Biologicals Announces New Nkx6.1 Antibody Made Using SDIX's Genomic Antibody Technology™

Novus Biologicals announced today a new Nkx6.1 antibody (catalog number NBP1-49672) for the study of Pancreatic Stem Cell Markers or Signal Transduction. This Nkx6.1 antibody was made using SDIX's Genomic Antibody TechnologyTM (GATTM). Homeobox protein Nkx-6.1 is a bifunctional transcription... - April 28, 2011 - Novus Biologicals

Novus Biologicals Announces New PINK1 Antibody Made Using SDIX Genomic Antibodies™

Novus Biologicals is excited to announce a new PINK1 antibody (catalog number NBP1-49678) for the study of mitochondrial markers and neurodegeneration. This PINK 1 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). PTEN-induced putative kinase 1 (PINK1) is a mitochondrial... - April 23, 2011 - Novus Biologicals

Carotech to Share Emerging Science Supporting Tocomin®SupraBio™ in Addressing Wellness During SupplySide East Expo, May 3 – 5, 2011

Meet them at Supplyside East (Booth 1710) to learn about the latest science of Tocomin®SupraBio™ - April 20, 2011 - Carotech Inc.

AnaSpec Introduces Industry’s First Zebrafish Specific Antibodies - Z-FishTM Anti-Lysozyme

AnaSpec, Eurogentec Group is pleased to be the first in the industry to establish a new product line of zebrafish specific (Z-Fish™) antibodies to support the increasing needs of researchers. In collaboration with the University of Utah, Salt Lake City, Utah, AnaSpec's Z-Fish™... - April 13, 2011 - AnaSpec, EGT Group

New APE1 Redox Inhibitor Molecule (E3330)

AP Endonuclease 1 (APE1), also known as REF-1, is an enzyme primarily responsible for DNA base excision repair. In addition to a DNA repair domain, APE-1 also contains a redox regulation domain to help activate other enzymes involved in the DNA repair pathway. APE 1 is found overexpressed in many... - April 07, 2011 - Novus Biologicals

TransEnterix Introduces New SPIDER Surgical System

Enhanced design delivers added strength, precision and ergonomics — through tiny incision the size of a dime. - April 01, 2011 - TransEnterix

TransEnterix Continues to Advance Laparoscopic Surgery Through Innovation

New line of 3mm SPIDER MicroLap™ surgical instruments paves way for "freckle" surgery. - March 25, 2011 - TransEnterix

VIRUN Patent Granted Mucosal Adhesive Penetrating Technology Delivering Naive Compounds and Peptides Orally

VIRUN Patent Granted Mucosal Adhesive Penetrating Technology Delivering Naive Compounds and Peptides Orally

VIRUN, Inc., a biotechnology research and manufacturer of novel encapsulation and delivery technologies has been granted patent number 7,906,140 titled Compositions for Mucosal Delivery of Agents. The patent was issued following the prosecution and due diligence performed by VIRUN and its team of scientists. - March 23, 2011 - VIRUN

Mitegen Announces Release of Dual Thickness MicroMounts™

Improved crystal mount for X-ray diffraction offers highest rigidity and lowest background scatter - March 22, 2011 - MiTeGen, LLC

Three New Histone Demethylase Antibodies Announced by Novus Biologicals

Novus Biologicals announced today the release of three new rabbit polyclonal antibodies to important histone demethylase proteins: JMJD2C (Catalog# NBP1-49600), JMJD1A (Catalog# NBP1-49601), and JMJD2A (Catalog# NBP1-49602). All three of these new antibodies cross-react with human and mouse... - March 20, 2011 - Novus Biologicals

C. elegans Antibodies from the modENCODE Project Now Available Through Novus Biologicals

Antibodies against 69 C. elegans chromosomal proteins generated by the modENCODE project are now commercially available through Novus Biologicals, SDIX’s pre-made antibody distributor. The modENCODE project (model organism ENCyclopedia Of DNA Elements) is funded by the NIH to identify all of... - March 20, 2011 - Novus Biologicals

Pacific Biomarkers CSO Elizabeth T. Leary Co-Authors Paper in March Issue of Clinical Chemistry

Article Explores the Contribution of Assay Methodologies in Risk Classification for Cardiovascular Disease - March 11, 2011 - Pacific Biomarkers Inc

Florida’s Only Female Bariatric Surgeon Adopts SPIDER Surgical System

New technology allows Dr. Tiffany Jessee to perform gastric-band procedure entirely through one incision. - March 10, 2011 - TransEnterix

Golgi Complex Marker - TGN46 Antibody Launched by Novus Biologicals

Novus Biologicals announces the release of a new rabbit polyclonal TGN46 Antibody for Golgi complex research. - March 09, 2011 - Novus Biologicals

Fort Worth Bariatric Surgeon Adopts SPIDER® System for Gastric Banding

As both surgeon and gastric band patient, Dr. Adam Smith appreciates system’s fewer incisions. - March 04, 2011 - TransEnterix

Pacific Biomarkers’ Dr. Amar A. Sethi Recognized by R&D Directions as One of Nine “Most Notable People in R&D”

Vice President of R&D Singled Out For Work In Seeking Clues to Heart-Disease Risk - March 03, 2011 - Pacific Biomarkers Inc

AnaSpec Introduces Cherry™Express T7 Protein Expression Kits

AnaSpec, Eurogentec Group is pleased to introduce CherryTMExpress T7 Protein Express Kits from Eurogentec. The Cherry™Express kit allows direct visualization through the whole process of T7 protein expression, production and purification without the need for any special requirements or... - February 24, 2011 - AnaSpec, EGT Group

AnaSpec Showcases Premium Quality of Fluorescent Nucleic Acid Probes

AnaSpec is pleased to showcase a variety of premium quality stains, including cell-impermeant and cell-permeant nucleic acid stains. The detection of nucleic acids is important for many life science research tasks, such as sequencing, cDNA synthesis and cloning, RNA transcription and transfection. - February 24, 2011 - AnaSpec, EGT Group

OSO BioPharmaceuticals to Sponsor Forum on Subcutaneous Biologic Drug Delivery Trends and Best Practices at DCAT Week

The 2011 DCAT Week Biologics Forum will present regulatory and pharmaceutical industry leaders discussing current requirements, trends and best practices for subcutaneous biologic drug delivery systems. - February 24, 2011 - OSO BioPharmaceuticals Manufacturing, LLC

Mitegen Announces Release of MicroRT™ Aligner

Alignment tool for preparing mounted crystals for room and variable temperature X-ray diffraction. - February 22, 2011 - MiTeGen, LLC

University of Miami Surgeon Removes Kidney Through Patient’s Belly Button

Using SPIDER Surgical System, Dr. Raymond J. Leveillee performs UHealth’s first single-incision nephrectomy. - February 20, 2011 - TransEnterix

AnaSpec Offers α & β-Synuclein Recombinant Proteins

AnaSpec, Eurogentec Group, is pleased to offer two recombinant proteins for use in Neurodegenerative Disease Research, α-synuclein (SNCA) and β-synuclein (SNCB). Both α-synuclein and β-synuclein are expressed and purified from E. coli. α-Synuclein is a 140-amino acid... - February 18, 2011 - AnaSpec, EGT Group

AnaSpec Signs Distribution Agreement with In Vitr

AnaSpec, Eurogentec Group and In Vitro have announced a non-exclusive distributor agreement that will allow In Vitro and its European branches to distribute AnaSpec’s catalog and custom products for Peptides, Fluorescent Dyes, Antibodies, Assay Kits, and Amino Acids throughout Europe. In... - February 18, 2011 - AnaSpec, EGT Group

AnaSpec Introduces SensoLyte® SIRT2 Assay Kits Fluorimetric

Expanding on their offerings of long wavelength, highly sensitive SIRT assays, AnaSpec, Eurogentec Group, is pleased to release 2 assay kits for SIRT2, the SensoLyte® 520 FRET SIRT2 Assay Kit and the SensoLyte® Green SIRT2 Assay Kit. The substrate found in the SensoLyte® 520 FRET SIRT2... - February 16, 2011 - AnaSpec, EGT Group

Tocomin Palm Tocotrienol Complex Won Ingredient of 2010 Award

Tocomin was selected because it has cutting edge science; is effective and natural. - February 12, 2011 - Carotech Inc.

Aciont® CEO to Present at IN3 West Medical Device Conference

John Higuchi will present on behalf of Aciont Inc at the IN3 West Medical Device Conference in Las Vegas, NV on February 22, 2011. - February 10, 2011 - Aciont Inc.

Oncolytics Biotech® Inc. Announces 2-Arm, Randomized Phase II Pancreatic Cancer Study

Oncolytics Biotech Inc. (“Oncolytics”) announced that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of... - February 04, 2011 - Oncolytics Biotech

Pacific Biomarkers Names Sheri’ DuMond as Its New Director of Business Development

Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, has promoted Sheri’ DuMond to Director of Business Development following her role as Senior Associate Director of Business Development at... - February 04, 2011 - Pacific Biomarkers Inc

Susan Schniepp, VP of Quality at OSO BioPharmaceuticals, Elected to PDA Board of Directors

Susan Schniepp, vice president of quality at OSO BioPharmaceuticals Manufacturing, LLC, has been elected to the board of directors at the Parenteral Drug Association (PDA). Schniepp has enjoyed a long and productive relationship with the PDA. In addition to serving on numerous committees and being... - January 28, 2011 - OSO BioPharmaceuticals Manufacturing, LLC

New Lin28 Antibody Announced by Novus Biologicals

Novus' new Lin28 antibody is useful for immunofluorescence, immunohistochemistry and Western blot. By Western blot, Lin28 antibodies recognize a band at approximately 29kDa. This new Lin28 antibody was validated by Western blot on NTERA-2 cell lysate and 293T cells overexpressing LIN28. - January 26, 2011 - Novus Biologicals

TransEnterix Lands Surgical Device Executive to Serve as Chief Technology Officer

Richard M. Mueller will oversee all aspects of company’s research and development, including rapid innovation. - January 24, 2011 - TransEnterix

AnaSpec Introduces Industry’s First Fluorimetric Assay - SensoLyte® Cathepsin G Kits

AnaSpec, Eurogentec Group, is pleased to announce the release of the industry's first fluorimetric kits for Cathepsin G, the SensoLyte® 520 Cathepsin G Assay Kit and SensoLyte® Rh110 Cathepsin G Assay Kit. These long-wavelength, homogeneous assays are ideal for the screening of enzyme... - January 22, 2011 - AnaSpec, EGT Group

AnaSpec Offers PEGylated Amino Acids

AnaSpec, Eurogentec Group, is pleased to highlight their wide collection of Fmoc- and Boc-protected PEGylated amino acids for PEGylated peptides synthesis. PEGylation has become a well-accepted method for the delivery of biopharmaceuticals-especially peptide and protein drugs.1-4 Simple... - January 22, 2011 - AnaSpec, EGT Group

Sustainable Now Technologies Appoints Ryan Dibble as Chief Financial Officer

Sustainable Now Technologies (SNT), a green technologies developer located in Signal Hill, California, has announced today the appointment of Ryan Dibble as Chief Financial Officer. - January 21, 2011 - Sustainable Now Technologies

OSO BioPharmaceuticals Taps Craig Mastenbaum to Lead West Coast Business Development

OSO BioPharmaceuticals Manufacturing, LLC, has named Craig Mastenbaum director of new business development for its West Coast market. Mastenbaum brings to OsoBio more than 30 years of leadership experience in clinical and contract liquid, lyophilized, ampule and syringe product manufacturing. Most... - January 21, 2011 - OSO BioPharmaceuticals Manufacturing, LLC

Mitegen Appoints New CEO

Mitegen Appoints New CEO

Mitegen LLC (“Mitegen”, the “Company), a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced today that Robert Newman has been appointed... - January 19, 2011 - MiTeGen, LLC

Synpromics Appoints Andrei Lyne as CFO

Synpromics Ltd. is pleased to announce that Andrei Lyne has joined the company as Chief Financial Officer. The new appointment demonstrates Synpromics’s commitment to build a world-class management team to fully exploit the exciting potential of its innovative technology. - January 19, 2011 - Synpromics Ltd

Oncolytics Biotech® Inc. Announces Opening of Enrollment in U.S. Phase I Colorectal Cancer Study

The principal investigator of the new colon cancer trial using Reolysin is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York. - January 13, 2011 - Oncolytics Biotech

Pacific Biomarkers, Inc. Announces Awards of Major Research Contracts

Pacific Biomarkers, Inc. (OTCBB: PBMC, “PBI”), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, announced today that it has been awarded two major research contracts with two multinational pharmaceutical companies (the... - January 13, 2011 - Pacific Biomarkers Inc

Fort Worth Bariatric Surgeon Adopts SPIDER® System for Gastric Banding

As both surgeon and gastric band patient, Dr. Adam Smith appreciates system’s fewer incisions - January 08, 2011 - TransEnterix

AnaSpec Introduces Industry’s First FRET-Based - SensoLyte® Green Elastase Assay Kits

AnaSpec, Eurogentec Group is pleased to introduce the SensoLyte® Green Elastase Assay Kit - the first FRET-based Elastase activity assay kit in the industry. This kit employs a natural substrate, elastin that is labeled with the 5-FAM fluorophore and the QXL™ 520 quencher. Proteolytic... - December 30, 2010 - AnaSpec, EGT Group

AnaSpec Expands Anti-GFP Collection – mAb & Chicken Polyclonal Antibodies

AnaSpec is pleased to expand their GFP antibodies offerings. The new GFP antibodies include two monoclonals raised in mouse and a third, a polyclonal raised in chicken. Purified green-fluorescent protein (GFP) was used as antigen. Antibody reactivity was confirmed by ELISA and specificity was... - December 30, 2010 - AnaSpec, EGT Group

AnaSpec Offers Double-Dye Oligo Synthesis Service

AnaSpec, Eurogentec Group is pleased to highlight our Double-Dye Oligo Synthesis Service. With over 20 years expertise of oligonucleotide synthesis, and Eurogentec production facilities in San Diego, California and Liege, Belgium, AnaSpec now offers the largest number of fluorescent reporters and... - December 22, 2010 - AnaSpec, EGT Group

AnaSpec Expands HCV NS3/4A Protease Selection

AnaSpec, Eurogentec Group is pleased to announce the expansion of their NS3/4A protease selection to include proteases from genotypes 1a, 1b, 2a, 3a and 4d. These recombinant HCV NS3/4A proteases are highly active and can be used with the SensoLyte® 490, 520, or 620 HCV Protease Assay Kits for... - December 22, 2010 - AnaSpec, EGT Group

Wockhardt Foundation & ONGC Come Together for Khel Khel Mein

ONGC partners for a noble cause with Wockhardt Foundation to help underprivileged children. - December 12, 2010 - Wockhardt Foundation

Anti-5-Methylcytidine Antibody from AnaSpec - Most Cited

AnaSpec, Eurogentec Group is pleased to offer anti-5-methylcytidine (Clone 33D3), Eurogentec’s most popular monoclonal antibody, for use in epigenetics research. 5-Methylcytidine is a modified base found in the DNA of plants and vertebrate. DNA methylation is a post-replication process... - December 11, 2010 - AnaSpec, EGT Group

AnaSpecs Offers Dyes for Labeling Amine- and Thiol-Modified Oligos

AnaSpec is pleased to highlight their own proprietary HiLyte Fluor dyes for labeling amine and thiol modified oligonucleotides from AnaSpec’s wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines. Fluorescent dye-labeled oligos are widely used as primers... - December 11, 2010 - AnaSpec, EGT Group

New THAP11 Antibody from Novus Biologicals

Novus Biologicals just announced a new THAP11 antibody (catalog # NBP1-49463). THAP11 antibodies, also known as Thanatos-associated protein 11 antibodies, are useful for cancer studies and stem cell research. THAP-11 is a regulator of embryonic stem cells and is in the same field as Oct4, Sox2 and Nanog. - December 09, 2010 - Novus Biologicals

Press Releases 951 - 1,000 of 1,360